开发双重向的可溶性环氧化酶抑制剂的策略
Weiwei Li1, Yanping Sun2, Shuo Li2
1Department of Pharmacy, School of Chemical and Pharmaceutical Engineering, Hebei University of Science and Technology, Shijiazhuang, 050018, China.
可溶性环氧化酶 (sEH) 的双抑制剂可提高复杂疾病的疗效和安全性. 这篇评论探讨了它们的设计,优化和治疗代谢,心血管和炎症疾病的潜力.
科学领域:
- 药理学 药理学是指药理学的学科.
- 药用化学 医学化学
- 药物发现 药物发现 药物发现
背景情况:
- 溶性环氧化酶 (sEH) 调节环氧化酸 (EETs),影响代谢,心血管,脑血管,炎症和疼痛通路.
- sEH是一种经过验证的治疗标,但单标抑制剂在复杂疾病的疗效和耐药性方面存在局限性.
- 多标药物发现,特别是双标抑制剂,是克服这些挑战的有希望的策略.
研究的目的:
- 系统地审查双标sEH抑制剂的研究进展.
- 分析这些连接体的理性设计,结构-活性关系 (SAR) 优化和转化前景.
- 为开发改进的多目标SEH治疗策略提供基础.
主要方法:
- 对双标sEH抑制剂的研究的文献综述.
- 对sEH配体的药物设计原理和SAR数据的分析.
- 对双重向药物的体内疗效和安全性数据的评估.
主要成果:
- 双标sEH抑制剂显示出协同途径调节,增强治疗疗效和降低耐药性.
- 这些抑制剂在体内疗效和安全性表现有所改善,与单一向药物相比.
- 证据支持对各种复杂疾病的双重向sEH抑制剂的潜力.
结论:
- 双向的sEH抑制剂比单向的方法具有显著的进步.
- 对合理设计和SAR优化的进一步研究对于临床翻译至关重要.
- 这些策略有望为一系列疾病开发更有效,更安全的治疗方法.
更多相关视频
08:31Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
相关概念视频
Sharpless Epoxidation
Preparation of Epoxides
Epoxides result from alkene oxidation, which can be achieved by a) air, b) peroxy acids, c) hypochlorous acids, and d) halohydrin cyclization.
Epoxidation with Peroxy Acids
Epoxidation of alkenes via oxidation with peroxy acids involves the conversion of a carbon–carbon double bond to an epoxide using the oxidizing agent meta-chloroperoxybenzoic acid, commonly known as MCPBA. Since the O–O bond of peroxy acids is very weak, the addition of electrophilic oxygen of peroxy acids to...
Base-Catalyzed Ring-Opening of Epoxides
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Oxidation of Alkenes: Syn Dihydroxylation with Osmium Tetraoxide
